Interestingly, all three cell lines demonstrate reduced Notch1 and the target genes Hey2 and Survivin expression consistently when the TRPM7 gene was silenced, implying that the decreased expression of TRPM7 is correlated with decreased Notch active component Notch1 NICD in all glioma cell lines tested. Here, TRPM7 is linked to central nervous system cancer.